Stable synthetic bacteriochlorins overcome the resistance of melanoma to photodynamic therapy
- Pawel Mroz
- , Ying Ying Huang
- , Angelika Szokalska
- , Timur Zhiyentayev
- , Sahar Janjua
- , Artemissia Phoebe Nifli
- , Margaret E. Sherwood
- , Christian Ruzié
- , K. Eszter Borbas
- , Dazhong Fan
- , Michael Krayer
- , Thiagarajan Balasubramanian
- , Eunkyung Yang
- , Hooi Ling Kee
- , Christine Kirmaier
- , James R. Diers
- , David F. Bocian
- , Dewey Holten
- , Jonathan S. Lindsey
- , Michael R. Hamblin
- Massachusetts General Hospital
- Harvard University
- Guangxi Medical University
- Medical University of Warsaw
- Massachusetts Institute of Technology
- Aga Khan University
- North Carolina State University
- NIRvana Pharmaceuticals, Inc.
- Washington University St. Louis
- University of California at Riverside
- Harvard-MIT Division of Health Sciences and Technology
Research output: Contribution to journal › Article › peer-review
101
Citations
(Scopus)